Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer

  • STATUS
    Recruiting
  • End date
    Apr 30, 2028
  • participants needed
    100
  • sponsor
    Hospital St. Joseph, Marseille, France
Updated on 30 April 2022

Summary

Evaluate the patient care recommandation induced by the IMMUNOSCORE® result

Details
Condition Non Metastatic Colorectal Cancer
Treatment IMMUNOSCORE®
Clinical Study IdentifierNCT04938986
SponsorHospital St. Joseph, Marseille, France
Last Modified on30 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

age between 18 and 80 inclusive
histologically confirmed colon adenocarcinoma
having undergone a curative resection of stage I, II or III colorectal cancer
diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2
eligible to receive 6 months of adjuvant chemotherapy
having given free, informed and written consent
agreeing to the use of a tumor sample for research purposes
being affiliated to a social security system

Exclusion Criteria

pregnant or breastfeeding women
legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study
history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
person subject to a safeguard measure
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note